Aurora Cannabis (ACB)
(Delayed Data from NSDQ)
$6.51 USD
+0.34 (5.51%)
Updated Aug 23, 2024 03:59 PM ET
After-Market: $6.51 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
C Value C Growth B Momentum B VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$6.51 USD
+0.34 (5.51%)
Updated Aug 23, 2024 03:59 PM ET
After-Market: $6.51 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
C Value C Growth B Momentum B VGM
Zacks News
Aurora Cannabis Inc. (ACB) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
by Zacks Equity Research
Aurora Cannabis Inc. (ACB) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Buy Cronos (CRON) Stock Ahead of Earnings as Bet on Marijuana Comeback?
by Benjamin Rains
Should investors think about buying some shares of Cronos (CRON) ahead of earnings, as a bet on a marijuana market comeback?
Aurora Cannabis Inc. (ACB) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
Aurora Cannabis Inc. (ACB) closed at $3.72 in the latest trading session, marking a -1.06% move from the prior day.
4 Highly-Ranked Cheap Stocks Trading Under $10 to Buy Right Now
by Benjamin Rains
Today we highlighted 4 'cheap' stocks that are currently trading for under $10 per share that also sport a Zacks Rank #2 (Buy) or better that investors might want to consider buying right now...
What's in the Offing for Humana's (HUM) Earnings in Q3?
by Zacks Equity Research
Humana's (HUM) third-quarter results are likely to reflect rise in expenses and a negative impact from seasonality on its bottom line.
Genesis Healthcare (GEN) to Post Q3 Earnings: What to Expect
by Zacks Equity Research
Genesis Healthcare's (GEN) third-quarter results are likely to reflect weak revenues, partially offset by same store facility growth and lower expenses.
Aurora Cannabis Inc. (ACB) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
by Zacks Equity Research
Aurora Cannabis Inc. (ACB) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
What's in the Cards for DaVita (DVA) This Earnings Season?
by Zacks Equity Research
DaVita (DVA) expects to have gained from calcimimetics in the third quarter.
What to Expect From Tenet Healthcare's (THC) Q3 Earnings
by Zacks Equity Research
Tenet Healthcare's (THC) third-quarter results are likely to reflect weaker revenues, partially offset by higher contribution from its Conifer segment.
Aurora Cannabis Inc. (ACB) Gains But Lags Market: What You Should Know
by Zacks Equity Research
Aurora Cannabis Inc. (ACB) closed the most recent trading day at $3.61, moving +0.28% from the previous trading session.
5 Top-Ranked Cheap Stocks Trading Under $20 to Buy Right Now
by Benjamin Rains
Today we found 5 cheap stocks currently trading for under $20 per share using our Zacks Stock Screener that investors might want to buy heading into November...
Should You Buy the Dip in Marijuana ETFs Ahead of Earnings?
by Sanghamitra Saha
Hexo's downbeat results weigh on marijuana space but many key pot companies are likely to beat in November. This could provide a good entry points to pot ETFs.
What's in the Cards for Zimmer Biomet's (ZBH) Q3 Earnings?
by Zacks Equity Research
In Spine & CMF, Zimmer Biomet (ZBH) is witnessing slowdown in growth due to difficult comps.
Aurora Cannabis Inc. (ACB) Gains But Lags Market: What You Should Know
by Zacks Equity Research
In the latest trading session, Aurora Cannabis Inc. (ACB) closed at $3.69, marking a +0.27% move from the previous day.
Can Overall Growth Boost Boston Scientific (BSX) Q3 Earnings?
by Zacks Equity Research
We are once again optimistic about the IC business of Boston Scientific (BSX), which is likely to have aided the company to retain impressive global growth in Q3.
What's in the Offing for LabCorp's (LH) Earnings in Q3?
by Zacks Equity Research
LabCorp (LH) is expected to have advanced its companion diagnostics and oncology capabilities in the third quarter.
Implied Volatility Surging for Aurora Cannabis (ACB) Stock Options
by Zacks Equity Research
Investors need to pay close attention to Aurora Cannabis (ACB) stock based on the movements in the options market lately.
How to Invest in Emerging Industries Like Marijuana
by Tracey Ryniec
Investors are still crazy about the pot stocks despite this year's roller coaster ride.
Aurora Cannabis Inc. (ACB) Gains As Market Dips: What You Should Know
by Zacks Equity Research
Aurora Cannabis Inc. (ACB) closed the most recent trading day at $4.15, moving +0.97% from the previous trading session.
Stocks Fall on U.S. Blacklist, China & the NBA and Buy Roku - Free Lunch
by Benjamin Rains
A look at the new U.S. blacklist on nearly 30 Chinese companies and how it might impact the upcoming trade talks. A dive into the dispute between the NBA and China, marijuana stocks, and why Roku is a Zacks Rank #1 (Strong Buy) - Free Lunch
Aurora Cannabis Inc. (ACB) Gains As Market Dips: What You Should Know
by Zacks Equity Research
In the latest trading session, Aurora Cannabis Inc. (ACB) closed at $4.15, marking a +0.73% move from the previous day.
Is Constellation Brands (STZ) Stock a Buy Heading into Q2 Earnings?
by Benjamin Rains
Should investors consider buying shares of Constellation Brands (STZ) as we head into the release of its second quarter fiscal 2020 earnings results, due out on Thursday, October 3?
Aurora Cannabis Inc. (ACB) Flat As Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, Aurora Cannabis Inc. (ACB) closed at $4.76, marking no change from the previous day.
Epidolex Progresses: Will the Marijuana Drug Market Boom?
by Indrajit Bandyopadhyay
Cannabis (or marijuana) based medical products have the potential to become the next booming industry.
Cannabis Industry to Scale New Highs Amid Legalization Woes
by Nilanjan Gupta
Legalization will likely drive commercial distribution of cannabis and boost growth of companies operating in this space.